D. Beauregard

发表

Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent

Ming Zhao, Kevin M. Brindle, Louiza Loizou, 2001, Nature Medicine.

One step bioconversion of waste precious metals into Serratia biofilm-immobilized catalyst for Cr(VI) reduction

M. Johns, D. Beauregard, L. Macaskie, 2015, Biotechnology Letters.

Early detection of tumour immune-rejection using magnetic resonance imaging

L. Thomsen, K. Brindle, D. Beauregard, 2003, British Journal of Cancer.

Dissection of the contributions toward dimerization of glycopeptide antibiotics

Joel P. Mackay, Dudley H. Williams, U. Gerhard, 1994 .

Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms

D. Williams, D. Beauregard, P. Reynolds, 1997, Antimicrobial agents and chemotherapy.

Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics

Dudley H. Williams, D. Williams, D. Beauregard, 1995, Antimicrobial agents and chemotherapy.

Glycopeptide antibiotic activity and the possible role of dimerization : A model for biological signaling

Dudley H. Williams, U. Gerhard, J. Mackay, 1994 .

Potent anti-metastatic activity of combretastatin-A4.

R. Hesketh, K. Brindle, D. Beauregard, 2001, International journal of oncology.

A Study of Biofilm and Non-Line-of-Sight Bio-Hydroxyapatite Coatings Using a Serratia sp.

Zhibing Zhang, M. Johns, D. Beauregard, 2009 .

Using non‐invasive magnetic resonance imaging (MRI) to assess the reduction of Cr(VI) using a biofilm–palladium catalyst

M. Johns, D. Beauregard, L. Macaskie, 2010, Biotechnology and bioengineering.

Seasonal variation in essential oil yield and composition from naturalized thymus vulgaris L. in New Zealand

M. H. Douglas, D. Beauregard, N. B. Perry, 1994 .

The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlates with vascular permeability.

K. Brindle, D. Beauregard, D. Chaplin, 2001, Cancer research.

Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.

K. Brindle, P. Thelwall, G. Adams, 1998, British Journal of Cancer.

Cooperativity between non-polar and ionic forces in the binding of bacterial cell wall analogues by vancomycin in aqueous solution.

D. Williams, D. Beauregard, H. Yan, 1995, The Journal of antibiotics.

Effects of postharvest treatments on yield and composition of coriander herb oil

K. Dodds, B. Smallfield, D. Beauregard, 1994 .

One step bioconversion of waste precious metals into Serratia biofilm-immobilized catalyst for Cr(VI) reduction

M. Johns, D. Beauregard, L. Macaskie, 2015, Biotechnology Letters.

Differential sensitivity of two adenocarcinoma xenografts to the anti‐vascular drugs combretastatin A4 phosphate and 5,6‐dimethylxanthenone‐4‐acetic acid, assessed using MRI and MRS

K. Brindle, D. Beauregard, R. Pedley, 2002, NMR in biomedicine.

Experiments Directed Towards the Synthesis of Anthracyclinones. XXVI. The Preparation of Chiral Intermediates for Anthracyclinone Synthesis

D. Beauregard, R. C. Cambie, P. Rutledge, 1995 .

Experiments Directed Towards the Synthesis of Anthracyclinones. XXI. Claisen Rearrangements of Some Mixed Allyl Ethers

D. Beauregard, R. C. Cambie, K. Higgs, 1994 .

Experiments Directed Towards the Synthesis of Anthracyclinones. Part 26. The Preparation of Chiral Intermediates for Anthracyclinone Synthesis.

D. Beauregard, R. C. Cambie, P. Rutledge, 1995 .

Enthalpic (electrostatic) contribution to the chelate effect: a correlation between ligand binding constant and a specific hydrogen bond strength in complexes of glycopeptide antibiotics with cell wall analogues

Dudley H. Williams, M. Searle, D. Beauregard, 1996 .